Checking vital signs in newborns with Lifelight software
Part of Genetic & congenital clinical trials.
This study tests a new camera-based software called Lifelight to measure vital signs like heart rate and breathing in newborns in the neonatal intensive care unit (NICU), compared to the usual monitors. It may offer a less intrusive way to monitor your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is currently in the neonatal intensive care unit (NICU).
- Your baby may be moved to a different hospital ward later.
- Your baby is not receiving palliative (comfort-only) care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wireless system to monitor and track newborns in hospital intensive care. Researchers want to understand how staff would use it and plan for hospital adoption.
This study checks how a newborn’s body changes over time in an intensive care unit, using routine monitoring. Your child may benefit by being closely observed, and the results may help improve care for future newborns.
This study tests a noninvasive way to continuously measure heart output (how well the heart is pumping) in newborn babies. It may help clinicians monitor babies more safely and adjust care sooner.
This study uses a painless light-based monitor to track how blood is moving in the brains of newborns during resuscitation. It may help doctors better understand what’s happening during care for very sick newborns.
This study tests a small, portable vital sign monitor for newborns right in the delivery room. It may be an option for babies born at 35 weeks or later who are healthy and stable after birth.
This trial tests advanced wireless sensors to monitor babies born at 35 weeks or later who are stable at delivery. The goal is to see if these sensors can improve care right after birth.
Hear when a new Vital Sign Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.